Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2006 | 06-2006 | 03-2006 | 12-2005 | 09-2005 | |
| Sales | 0 | 0 | 0 | 11 | 2 |
| Gross Profit | 0 | 0 | 0 | 6 | 2 |
| Operating Expenses | 5,540 | 5,240 | 4,030 | 3,870 | 3,130 |
| Operating Income | -5,540 | -5,240 | -4,030 | -3,859 | -3,128 |
| Interest Expense | 3 | 1,780 | 1,830 | 80 | 60 |
| Other Income | 663 | 540 | 70 | -61 | 118 |
| Pre-tax Income | -4,880 | -6,480 | -5,790 | -4,000 | -3,070 |
| Net Income Continuous | -4,886 | -6,488 | -5,799 | -3,990 | -3,078 |
| Net Income | $-4,886 | $-6,488 | $-5,799 | $-3,990 | $-3,078 |
| EPS Basic Total Ops | -8.80 | -14.40 | -40.79 | -28.79 | -21.60 |
| EPS Basic Continuous Ops | -8.57 | -14.48 | -40.52 | -27.90 | -21.54 |
| EPS Diluted Total Ops | -8.80 | -14.40 | -40.79 | -28.79 | -21.60 |
| EPS Diluted Continuous Ops | -8.57 | -14.48 | -40.52 | -27.90 | -21.54 |
| EBITDA(a) | $-5,430 | $-3,440 | $-2,240 | $-3,799 | $-3,058 |